|
Real-time Estimate
Cboe BZX
17:09:59 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.080 USD | -2.70% |
|
0.00% | -52.36% |
| 10-26 | Spero Therapeutics, Inc. Announces Executive Changes | CI |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.70% | 0.00% | -8.26% | -7.50% | -52.36% | -52.97% | +7.77% | -93.67% | - | 64.64M | |
| +0.34% | +1.12% | -11.06% | +12.96% | +57.65% | +34.75% | +61.06% | +3.54% | - | 64.38B | |
| +0.40% | +3.25% | -4.63% | +8.17% | +12.67% | +14.98% | +84.64% | +205.33% | +5,668.57% | 56.16B | |
| +0.91% | +2.25% | +12.31% | +13.29% | +20.12% | +15.69% | +107.38% | -15.36% | +245.82% | 54.16B | |
| -1.96% | -2.51% | +1.31% | +14.54% | +20.83% | +25.82% | +53.74% | +5.20% | +279.65% | 45.33B | |
| -0.14% | -1.23% | +1.92% | +15.80% | +22.76% | +21.01% | +99.87% | +4.34% | +1,022.05% | 42.25B | |
| -0.84% | +1.13% | -7.87% | -1.59% | +137.43% | +221.23% | +930.57% | +507.68% | - | 40.78B | |
| +1.95% | +47.01% | +65.90% | +110.79% | +91.76% | +111.31% | +95.23% | +35.48% | +247.67% | 33.8B | |
| -0.26% | -2.57% | +5.81% | +5.17% | +9.81% | +12.55% | +45.18% | +14.84% | +157.79% | 32.25B | |
| -1.29% | -2.88% | -20.64% | +17.67% | +41.48% | +21.60% | -11.92% | -60.11% | - | 23.57B | |
| -0.91% | +0.94% | -9.52% | -4.21% | -6.58% | -15.03% | -4.62% | -67.58% | - | 22.39B | |
| +1.34% | +21.30% | -0.75% | +11.62% | -34.91% | -41.67% | +375.97% | +264.83% | +772.73% | 24.37B | |
| -1.86% | +0.09% | +7.31% | +15.82% | +19.25% | +15.41% | +177.00% | +195.83% | +2,208.03% | 18.95B | |
| -3.02% | +7.25% | +25.56% | +57.88% | +85.69% | +106.81% | +125.15% | -15.87% | +388.15% | 17.95B | |
| +1.40% | +4.20% | +17.68% | +28.66% | +41.44% | +45.60% | +88.87% | -14.81% | +113.24% | 16.88B | |
| +6.71% | +10.52% | +22.10% | +27.43% | +62.72% | +83.15% | +252.37% | +228.66% | +573.47% | 16.4B | |
| -0.66% | +4.18% | +11.29% | +0.99% | - | - | - | - | - | 16.62B | |
| -3.29% | +12.50% | +22.61% | +25.91% | +14.38% | +26.07% | -12.47% | -27.86% | +159.62% | 16.14B | |
| +3.33% | +6.90% | +3.77% | +14.81% | +192.66% | +177.32% | +360.46% | +1,470.41% | +825.12% | 15.77B | |
| -6.68% | +10.48% | -8.79% | +68.66% | +26.50% | -13.41% | - | - | - | 14.05B | |
| Average | -0.38% | +6.18% | +6.30% | +21.84% | +40.17% | +42.64% | +157.57% | +146.72% | +973.99% | 28.61B | |
| Weighted average by Cap. | -0.13% | +5.08% | +5.17% | +20.44% | +42.64% | +46.25% | +164.85% | +123.54% | +1,269.26% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
